Øresund Pharma ApS: Financial statements 2025
CVR: 39492059
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Øresund Pharma ApS (CVR 39492059) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 39,702,011 and a net result of DKK 6,466,876 compared with DKK 13,707,320 the year before. That is an increase of 0.2% compared with the year before. Equity in the 2025 report amounted to DKK 44,617,595. The solvency ratio was 35%. The company had 16 employees in the financial year.
- Gross Profit
- DKK 39,702,011
- Profit/Loss
- DKK 6,466,876
- Equity
- DKK 44,617,595
- Total Assets
- DKK 127,580,477
- Employees
- 16
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 39.7 mio. | 6.5 mio. | 44.6 mio. | 16 |
| 2024 | - | 39.6 mio. | 13.7 mio. | 38.2 mio. | 11 |
| 2023 | - | 38.3 mio. | 16.8 mio. | 24.4 mio. | 9 |
| 2022 | - | 17.2 mio. | 4.3 mio. | 7.7 mio. | 6 |
| 2021 | - | 7.3 mio. | 281 t. | 3.4 mio. | 5 |
Official annual report
How creditworthy is Øresund Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Øresund Pharma ApS has won the tender "Amgros 2026 1.1212.a" issued by Amgros I/S worth 44,707,811 DKK.
Øresund Pharma ApS has won the tender "Amgros 2026 1.470.a" issued by Amgros I/S worth 20,500,000 DKK.
Øresund Pharma ApS has won the tender "Amgros 2026 1.1201.a" issued by Amgros I/S worth 358,514,920 DKK.
Øresund Pharma ApS has won the tender "Amgros 2026 1.1203.a" issued by Amgros I/S worth 368,505,024 DKK.
Øresund Pharma ApS has won the tender "Amgros 2026 1.1210.a" issued by Amgros I/S worth 104,066,115 DKK.
Øresund Pharma ApS has won the tender "Amgros 2026 2.790.b" issued by Amgros I/S worth 66,631,361 DKK.
Øresund Pharma ApS has won the tender "Amgros 2026 1.704.b" issued by Amgros I/S worth 32,900,000 DKK.
As of August 19, 2025, BDO Statsautoriseret Revisionspartnerselskab has been appointed auditor of Øresund Pharma ApS.
As of August 19, 2025, A/S PSE 17 NR. 1056 has stepped down as auditor of Øresund Pharma ApS.
Øresund Pharma ApS has published its annual report for 2024. Gross profit came to DKK 39,622,065, and the net result was DKK 13,707,320.
About Øresund Pharma ApS
Øresund Pharma ApS is a Danish company of the type Anpartsselskab based in Nordhavn, founded in 2018. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Øresund Pharma IVS. The management consists of Patrick Halborg Cohn and Svend Aage Johansen. The company is owned by Machpali ApS and ESH Holding 2019 ApS. The company has 21 employees (2026). In 2025, the company reported a gross profit of DKK 39,702,011 and a net result of DKK 6,466,876 compared with DKK 13,707,320 the year before. Equity in the 2025 report amounted to DKK 44,617,595.